수의용 항생제 시장 보고서(2026년)
Veterinary Antibiotics Global Market Report 2026
상품코드 : 1938707
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,691,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,672,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,652,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

수의용 항생제 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 23억 4,000만 달러에서 2026년에는 25억 4,000만 달러로, CAGR 8.3%로 확대할 전망입니다. 지난 수년간의 성장 요인으로는 가축의 세균 감염 확산, 반려동물 증가, 초기 건강관리 접근성 제한, 기존 주사용 항생제 제제, 동물복지에 대한 인식 증가 등을 꼽을 수 있습니다.

수의용 항생제 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 35억 달러에 달하며, CAGR은 8.4%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 수의학 분야에서의 정밀의료 도입, 경구제 및 프리믹스 제제의 혁신, 항생제 적정 사용에 대한 규제 지원, 반려동물 사육 수와 지출 증가, 항생제 투여시 디지털 모니터링의 통합 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 항균제 및 항기생충제 수요 증가, 반려동물용 항생제 사용 확대, 투여 편의성을 고려한 경구용 액제 및 프리믹스로의 전환, 가축 통증 관리에 있으며, 비스테로이드성 항염증약(NSAIDs)에 대한 관심 증가, 다기능성 동물용 항생제 제제 개발 등을 들 수 있습니다. 등을 들 수 있습니다.

향후 수년간 반려동물 양육률 증가는 동물용 항생제 시장의 성장을 촉진할 것으로 예측됩니다. 반려동물 양육은 반려동물로 가축화된 동물을 반려동물로 돌보는 법적으로 인정된 책임 있는 행위를 의미하며, 신체적, 정서적, 의료적 필요에 대한 대응을 포함합니다. 외로움을 줄이고 정서적 행복감을 향상시키기 위해 더 많은 개인과 가족이 반려동물을 키우게 되면서 반려동물 보유율은 증가하는 추세입니다. 동물용 항생제는 반려동물의 건강 유지와 질병 예방을 통해 이러한 추세를 지원하고, 반려동물 보호자에게 반려동물을 제대로 돌볼 수 있다는 확신을 제공합니다. 예를 들어 2024년 10월 기준 미국 수의사협회(미국 비영리 전문단체)에 따르면 2024년 미국의개 사육 가구 수는 5,980만 가구(전체 가구의 45.5%), 고양이 사육 가구 수는 4,210만 가구(전체 가구의 32.1%)에 달할 것으로 예측했습니다. 따라서 반려동물 사육률 증가는 동물용 항생제 시장을 촉진하고 있습니다.

수의용 항생제 시장의 주요 기업은 경쟁 우위를 확보하기 위해 반려동물 건강관리를 위한 원격의료 플랫폼 개발을 추진하고 있습니다. 원격의료란 화상통화, 전화상담, 안전한 메시징 플랫폼 등의 통신기술을 이용하여 환자의 원격 진단, 상담, 치료, 모니터링 등을 수행하는 것을 말합니다. 예를 들어 2023년 6월 미국 식품 대기업 카길(Cargill)은 디지털 애완동물 케어 앱 '주니벳(Zoonivet)'을 출시했습니다. 이 원격 헬스케어 플랫폼은 화상 상담을 통해 반려동물 보호자와 자격을 갖춘 수의사를 연결하여 반려동물 건강관리를 효율화하고, 1차 의료 서비스를 쉽고 편리하게 이용할 수 있도록 돕습니다. Zoonivet은 인도 주요 시장에서 외과수술, 재택 진단 서비스, 의약품, 반려동물 사료, 반려동물 호텔도 제공할 계획입니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Veterinary antibiotics constitute a category of animal medications designed to combat infectious diseases in animals. They achieve this by eliminating microorganisms such as bacteria and parasites, hindering the growth of their cell walls to effectively combat infections and diseases in animals, thereby enhancing the health conditions of the animals.

The primary product types within veterinary antibiotics encompass anti-parasitic drugs, anti-bacterial medications, non-steroidal anti-inflammatory drugs (NSAIDs), and other related products. NSAIDs serve as a connection point between the production and activity of prostaglandins (enzymes) involved in inflammation. Approved veterinary NSAIDs find application in companion animal care, specifically in mitigating pain and swelling associated with osteoarthritis in dogs and horses. The administration of veterinary antibiotics includes various methods such as premixes, injections, oral powders, oral solutions, and other forms, catering to both farm animals and companion animals.

Tariffs have influenced the veterinary antibiotics market by increasing the cost of imported drugs, premixes, and production equipment. Segments such as anti-bacterial and anti-parasitic drugs are most affected, particularly in Asia-Pacific, North America, and Europe where imports dominate supply chains. While tariffs raise costs, they may incentivize local production, enhance domestic research, and encourage development of cost-effective antibiotic solutions.

The veterinary antibiotics market research report is one of a series of new reports from The Business Research Company that provides veterinary antibiotics market statistics, including veterinary antibiotics industry global market size, regional shares, competitors with a veterinary antibiotics market share, detailed veterinary antibiotics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary antibiotics industry. This veterinary antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary antibiotics market size has grown strongly in recent years. It will grow from $2.34 billion in 2025 to $2.54 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to prevalence of bacterial infections in livestock, growth of companion animal population, limited early veterinary healthcare access, traditional injectable antibiotic formulations, rising awareness of animal welfare.

The veterinary antibiotics market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to adoption of precision medicine in veterinary care, innovation in oral and premix formulations, regulatory support for antibiotic stewardship, increasing pet ownership and spending, integration of digital monitoring in antibiotic administration. Major trends in the forecast period include rising demand for anti-bacterial and anti-parasitic drugs, expansion of companion animal antibiotic usage, shift toward oral solutions and premixes for easy administration, increasing focus on nsaids for livestock pain management, development of multi-functional veterinary antibiotic formulations.

The increasing pet ownership rate is expected to drive the growth of the veterinary antibiotics market in the coming years. Pet ownership refers to the legally recognized and responsible act of caring for domesticated animals as companions, which includes addressing their physical, emotional, and medical needs. This rate is rising due to a growing desire for companionship, as more individuals and families adopt pets to reduce loneliness and enhance emotional well-being. Veterinary antibiotics support this trend by keeping pets healthy and disease-free, providing owners with confidence in their ability to care for them. For example, in October 2024, according to the American Veterinary Medical Association, a US-based nonprofit professional association, the total number of dog-owning households in the U.S. is projected to reach 59.8 million in 2024 (45.5% of all U.S. households), while cat-owning households are expected to total 42.1 million (32.1% of all U.S. households). Therefore, the rising pet ownership rate is boosting the veterinary antibiotics market.

Key players in the veterinary antibiotics market are developing telemedicine platforms for pet healthcare to gain a competitive advantage. Telemedicine involves the remote diagnosis, consultation, treatment, and monitoring of patients using telecommunications technologies such as video calls, phone consultations, or secure messaging platforms. For instance, in June 2023, Cargill Inc., a US-based food corporation, launched Zoonivet, a digital pet-care app. This telehealth platform streamlines pet healthcare by connecting pet owners with qualified veterinarians via video consultations, making primary care accessible and convenient. Zoonivet also plans to offer surgery, home diagnostic services, medication, pet food, and pet boarding across key Indian markets.

In July 2024, Merck Animal Health, a US-based provider of veterinary pharmaceuticals, vaccines, nutritionals, and health management solutions for livestock, companion animals, and aquaculture, acquired Elanco Animal Health Incorporated's aqua business for approximately $1.3 billion. Through this acquisition, Merck aims to expand its global aquaculture portfolio and strengthen its scientific and commercial capabilities across warm-water and cold-water products to better support fish health, welfare, and sustainability. Elanco Animal Health Incorporated is a US-based provider of aquaculture-focused health solutions, including vaccines, anti-parasitic treatments, water supplements, and nutrition products for aquatic species, along with associated manufacturing and research operations.

Major companies operating in the veterinary antibiotics market are Boehringer Ingelheim GmbH, Zoetis, Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Dechra Pharmaceuticals plc, Bayer Animal Health China, China Animal Healthcare Ltd., China Animal Husbandry Industry Corporation Ltd. (CAHIC), Guangdong Wens Dahuanong Biotechnology Co. Ltd., Merial Pulike Biological Engineering, Ceva Sante Animale, Nimrod Veterinary Products Ltd., Bimeda, VIRBAC SA, Orion Animal Health, Laboratorios Calier, SA, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Lamons Laboratories SA, SUPER'S DIANA, Swetrade Pharmaceuticals AB, Animalcare, VIC Animal Health, AVZ animal health, Provet Group, VitOMEK LCC, Micro-plus, Biowet, Bioveta, Brovapharma, Evrovet, Ukrvetprompostach, VELELEK d.o.o, Veterinarski Zavod Subotica, VetPlanet, Delos Medica, Vetro Solutions, Belfarmacom, IDT Biologika, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Saudi Pharmaceutical Industries (SPI), DBK Pharma S.A.E.

North America was the largest region in the veterinary antibiotics market in 2025. Asia-Pacific was the second-largest region in the global veterinary antibiotics market share. The regions covered in the veterinary antibiotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary antibiotics market consists of sales of antivirals, antiprotozoals, antifungals, aminoglycosides, beta-lactams, fluoroquinolones, glycopeptides, and lipopeptides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Antibiotics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary antibiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Veterinary Antibiotics Market Characteristics

3. Veterinary Antibiotics Market Supply Chain Analysis

4. Global Veterinary Antibiotics Market Trends And Strategies

5. Veterinary Antibiotics Market Analysis Of End Use Industries

6. Veterinary Antibiotics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Antibiotics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Veterinary Antibiotics Total Addressable Market (TAM) Analysis for the Market

9. Veterinary Antibiotics Market Segmentation

10. Veterinary Antibiotics Market Regional And Country Analysis

11. Asia-Pacific Veterinary Antibiotics Market

12. China Veterinary Antibiotics Market

13. India Veterinary Antibiotics Market

14. Japan Veterinary Antibiotics Market

15. Australia Veterinary Antibiotics Market

16. Indonesia Veterinary Antibiotics Market

17. South Korea Veterinary Antibiotics Market

18. Taiwan Veterinary Antibiotics Market

19. South East Asia Veterinary Antibiotics Market

20. Western Europe Veterinary Antibiotics Market

21. UK Veterinary Antibiotics Market

22. Germany Veterinary Antibiotics Market

23. France Veterinary Antibiotics Market

24. Italy Veterinary Antibiotics Market

25. Spain Veterinary Antibiotics Market

26. Eastern Europe Veterinary Antibiotics Market

27. Russia Veterinary Antibiotics Market

28. North America Veterinary Antibiotics Market

29. USA Veterinary Antibiotics Market

30. Canada Veterinary Antibiotics Market

31. South America Veterinary Antibiotics Market

32. Brazil Veterinary Antibiotics Market

33. Middle East Veterinary Antibiotics Market

34. Africa Veterinary Antibiotics Market

35. Veterinary Antibiotics Market Regulatory and Investment Landscape

36. Veterinary Antibiotics Market Competitive Landscape And Company Profiles

37. Veterinary Antibiotics Market Other Major And Innovative Companies

38. Global Veterinary Antibiotics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Antibiotics Market

40. Veterinary Antibiotics Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기